J. L. Jiménez

发表

Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy.

A. López-Guillermo, A. Salar, S. Mercadal, 2019, Hematology/oncology and stem cell therapy.

Progression‐free survival at 2 years post‐autologous transplant: a surrogate end point for overall survival in follicular lymphoma

A. López-Guillermo, A. Salar, S. Mercadal, 2017, Cancer medicine.

Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease

J. Miguel, A. Oriol, J. Besalduch, 2012, Haematologica.

Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment

A. López-Guillermo, A. Salar, S. Mercadal, 2018, Hematological oncology.

A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia

A. Nagler, I. Dufva, G. Martinelli, 2014, Blood Cancer Journal.

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

H. Waskin, A. Langston, I. Raad, 2016, The Journal of antimicrobial chemotherapy.

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.

H. Waskin, A. Langston, I. Raad, 2016, The Journal of antimicrobial chemotherapy.

High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance

E. González-Barca, M. Ramírez, I. Jarque, 2019, Haematologica.

Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Followed By HDT-ASCT, Consolidation with Krd and Maintenance with Rd

N. Puig, M. Calasanz, A. Oriol, 2018, Blood.

Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient.

E. Pedrosa, J. Mensa, R. C. Cáncer, 2011, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Salvage Therapy with Obinutuzumab (GA101) Plus Chlorambucil (Clb) after Treatment Failure of Clb Alone in Patients with Chronic Lymphocytic Leukemia (CLL) and Comorbidities: Results of the CLL11 Study

M. Dyer, G. Fingerle-Rowson, M. Hallek, 2014 .

Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry

A. López-Guillermo, A. Salar, S. Mercadal, 2018, Bone Marrow Transplantation.

Specific Intensive Chemotherapy Plus Rituximab for Advanced Burkitt’s Lymphoma or Leukemia in HIV-Positive and Negative Adult Patients.

J. Esteve, L. Escoda, A. Oriol, 2007 .

Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens

E. Ruiz-Mateos, M. Leal, M. Muñoz-Fernández, 2017, Journal of Translational Medicine.

Maintenance Treatment with Lenalidomide for Multiple Myeloma Increases the Proportion of MRD Negative (Flow-/PET-CT-) Patients

J. Lahuerta, M. Cedena, J. Martínez-López, 2017 .

Prevalence of JAK2 V617F in Individuals That Meet World Health Organization Erythrocytosis Criteria for Polycythemia Vera

J. Zamora, J. Villarrubia, M. Piris-Villaespesa, 2018, Blood.

Retrospective Non-Interventional Assessment of the Use of Idelalisib in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients in Spain

E. González-Barca, H. Ramroth, Á. Payer, 2019, Blood.